Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
New Bioeth ; 29(4): 340-351, 2023 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-37768733

RESUMO

I argue against responsibility arguments that offer a defence of abortion even on the assumption that the fetus is a person. I focus on argumentation originally offered by Judith Jarvis Thomson and then later defended by David Boonin. I offer thought experiments meant to show that, under certain conditions, one bears moral responsibility for creating a fetus. I then offer a positive argument for when one is morally responsible for the creation of a fetus. This argument relies on the presence of other forms of sex that reasonably approximate the goods of penile-vaginal intercourse. Given the presence of these options, sexual partners who engage in penile-vaginal intercourse bear moral responsibility for the creation of the fetus. While I do not think this argument settles the abortion debate - there still may be other ways to successfully defend abortion - it does explain why responsibility arguments like those offered by Thomson fail.


Assuntos
Aborto Induzido , Aborto Espontâneo , Gravidez , Feminino , Humanos , Pessoalidade , Obrigações Morais , Feto , Início da Vida Humana
2.
Health Care Anal ; 28(4): 434, 2020 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-33140221

RESUMO

The original version of this article unfortunately contained a mistake. The fourth sentence of third paragraph under section Do Harm Reduction Programs Condone Harm? Should be "One of us (Corvino)" instead of "One of us (name removed for blinded manuscript)".The original article has been corrected.

3.
Health Care Anal ; 28(4): 352-361, 2020 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-33048314

RESUMO

At first glance, it seems difficult to object to any program that merits the label "harm reduction." If harm is bad, as everyone recognizes, then surely reducing it is good. What's the problem? The problem, we submit, is twofold. First, there's more to "harm reduction," as that term is typically used, than simply the reduction of harm. Some of the wariness about harm-reduction programs may result from the nebulous "more." Thus, part of our task is to provide a clear definition of harm reduction. Next, we turn to a second problem: a worry about complicity. Those who object to harm reduction programs fear that participation in such programs would make them complicit in activities they deem immoral. In this paper we argue that this fear is largely unwarranted. We use supervised injection sites (SISs)-safe spaces for the use of risky drugs-as our paradigmatic case of harm reduction. These SISs are generally offered in the hope of reducing harm to both the drug user and the public. For this reason, our analysis focuses on complicity in harm. We draw upon the work of Gregory Mellema as our framework. Mellema offers three ways one can be complicit in harm caused by another: by enabling, facilitating or condoning it. We argue that one who operates an SIS is not complicit in any of these ways, while also laying out the conditions that must be met if one is to argue that harm reduction entails complicity in non-consequentialist wrongdoing.


Assuntos
Cumplicidade , Redução do Dano , Programas de Troca de Agulhas , Humanos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA